News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,546 Results
Type
Article (44148)
Company Profile (476)
Press Release (695910)
Multimedia
Podcasts (125)
Webinars (20)
Section
Business (209773)
Career Advice (2098)
Deals (36197)
Drug Delivery (120)
Drug Development (84028)
Employer Resources (176)
FDA (16734)
Job Trends (15230)
News (354847)
Policy (33367)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2668)
Accelerated approval (35)
Adcomms (28)
Allergies (146)
Alliances (51233)
ALS (178)
Alzheimer's disease (1733)
Antibody-drug conjugate (ADC) (330)
Approvals (16973)
Artificial intelligence (552)
Autoimmune disease (160)
Automation (39)
Bankruptcy (373)
Best Places to Work (11876)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (333)
Bladder cancer (162)
Brain cancer (60)
Breast cancer (656)
Cancer (4958)
Cardiovascular disease (420)
Career advice (1776)
Career pathing (39)
CAR-T (294)
CDC (47)
Celiac Disease (2)
Cell therapy (784)
Cervical cancer (36)
Clinical research (71492)
Collaboration (1817)
Company closure (4)
Compensation (1179)
Complete response letters (64)
COVID-19 (2776)
CRISPR (99)
C-suite (891)
Cystic fibrosis (152)
Data (6331)
Decentralized trials (2)
Denatured (41)
Depression (142)
Diabetes (508)
Diagnostics (6784)
Digital health (51)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (271)
Drug pricing (196)
Drug shortages (29)
Duchenne muscular dystrophy (245)
Earnings (91485)
Editorial (62)
Employer branding (21)
Employer resources (156)
Events (121271)
Executive appointments (1016)
FDA (19898)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1539)
Gene editing (215)
Generative AI (45)
Gene therapy (649)
GLP-1 (1014)
Government (4781)
Grass and pollen (6)
Guidances (384)
Healthcare (19334)
HIV (60)
Huntington's disease (46)
IgA nephropathy (87)
Immunology and inflammation (277)
Immuno-oncology (63)
Indications (111)
Infectious disease (3054)
Inflammatory bowel disease (198)
Inflation Reduction Act (17)
Influenza (121)
Intellectual property (253)
Interviews (331)
IPO (16943)
IRA (53)
Job creations (3719)
Job search strategy (1477)
JPM (66)
Kidney cancer (16)
Labor market (85)
Layoffs (582)
Leadership (35)
Legal (8034)
Liver cancer (94)
Longevity (14)
Lung cancer (667)
Lymphoma (382)
Machine learning (43)
Management (62)
Manufacturing (814)
MASH (171)
Medical device (13987)
Medtech (14040)
Mergers & acquisitions (20332)
Metabolic disorders (1325)
Multiple sclerosis (165)
NASH (19)
Neurodegenerative disease (341)
Neuropsychiatric disorders (97)
Neuroscience (3028)
Neurotech (1)
NextGen: Class of 2026 (6825)
Non-profit (4615)
Now hiring (67)
Obesity (634)
Opinion (286)
Ovarian cancer (168)
Pain (205)
Pancreatic cancer (234)
Parkinson's disease (294)
Partnered (34)
Patents (501)
Patient recruitment (504)
Peanut (57)
People (60586)
Pharmaceutical (85)
Pharmacy benefit managers (30)
Phase 1 (22484)
Phase 2 (31522)
Phase 3 (23300)
Pipeline (5357)
Policy (298)
Postmarket research (2603)
Preclinical (9614)
Press Release (67)
Prostate cancer (248)
Psychedelics (56)
Radiopharmaceuticals (298)
Rare diseases (897)
Real estate (6072)
Recruiting (71)
Regulatory (25080)
Reports (52)
Research institute (2508)
Resumes & cover letters (359)
Rett syndrome (27)
RNA editing (21)
RSV (77)
Schizophrenia (156)
Series A (255)
Series B (202)
Service/supplier (11)
Sickle cell disease (104)
Special edition (26)
Spinal muscular atrophy (162)
Sponsored (42)
Startups (3812)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (86)
The Weekly (82)
Vaccines (1037)
Venture capital (96)
Weight loss (411)
Women's health (93)
Worklife (19)
Date
Today (34)
Last 7 days (629)
Last 30 days (2185)
Last 365 days (30762)
2026 (3540)
2025 (31139)
2024 (36348)
2023 (41079)
2022 (52354)
2021 (56849)
2020 (55069)
2019 (47625)
2018 (35862)
2017 (33119)
2016 (32469)
2015 (38521)
2014 (32273)
2013 (27251)
2012 (29339)
2011 (29951)
2010 (28206)
Location
Africa (764)
Alabama (89)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (40818)
Australia (6785)
California (11522)
Canada (3317)
China (1144)
Colorado (487)
Connecticut (497)
Delaware (339)
Europe (89629)
Florida (1701)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (887)
India (66)
Indiana (525)
Iowa (24)
Japan (439)
Kansas (130)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1413)
Massachusetts (8378)
Michigan (327)
Minnesota (644)
Mississippi (5)
Missouri (130)
Montana (34)
Nebraska (28)
Nevada (124)
New Hampshire (83)
New Jersey (3066)
New Mexico (31)
New York (3021)
North Carolina (1540)
North Dakota (9)
Northern California (5605)
Ohio (340)
Oklahoma (21)
Oregon (45)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (49)
South America (1134)
South Carolina (67)
South Dakota (1)
Southern California (4469)
Tennessee (175)
Texas (1772)
United States (40996)
Utah (341)
Vermont (1)
Virginia (270)
Washington D.C. (82)
Washington State (957)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
740,546 Results for "guided therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Analysis of Guided Therapeutics’ FDA Study Data Reveals Compelling Clinical Need for LuViva
December 18, 2025
·
3 min read
Press Releases
InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform
January 8, 2026
·
3 min read
Press Releases
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
November 20, 2025
·
2 min read
Press Releases
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
December 4, 2025
·
5 min read
Press Releases
Glidewell Opens Applications for the 2026 Guiding Leaders Program
January 9, 2026
·
2 min read
Press Releases
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
August 14, 2025
·
3 min read
Press Releases
Renew Biotechnologies Advances Epigenetic Diagnostics Through Launch of Path Fertility’s NOA Guide
January 30, 2026
·
2 min read
Press Releases
Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline
February 10, 2026
·
7 min read
Press Releases
Sale of Intellectual Property – Mythic Therapeutics Inc.
December 23, 2025
·
1 min read
Press Releases
Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)
January 13, 2026
·
9 min read
1 of 74,055
Next
